
Medifast (MED) P/E Ratio
P/E Ratio as of Sep 23, 2025: 42.66
Average42.62
Median42.54
Minimum41.11
Maximum44.21
42.66
Past Month-0.70 (1.61%)
The P/E ratio for Medifast (MED) is 42.66 as of Sep 23, 2025. This represents a increase of 165.46% compared to its 12-month average P/E ratio of 16.07. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Medifast P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Medifast’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Medifast to industry peers.
Medifast P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Medifast’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Medifast to industry peers.
Medifast (MED) P/E Ratio Insights
See Medifast’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Medifast (MED)
Order type
Buy in
Order amount
Est. shares
0 shares
Medifast (MED) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Sep 2, 2025 | $13.92 | 42.23 |
Aug 1, 2025 | $13.75 | -21.48 |
Jul 1, 2025 | $14.67 | -22.91 |
Jun 2, 2025 | $13.32 | -20.81 |
May 1, 2025 | $12.98 | -20.27 |
Apr 1, 2025 | $13.14 | 69.45 |
Mar 3, 2025 | $14.02 | 74.10 |
Feb 3, 2025 | $15.32 | 22.92 |
Jan 2, 2025 | $17.29 | 25.87 |
Medifast (MED) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 42.66 | +61.77% |
2024 | 26.37 | +330.18% |
2023 | 6.13 | -29.86% |
2022 | 8.74 | -42.04% |
2021 | 15.08 | -33.30% |
2020 | 22.61 | — |
FAQs About Medifast (MED) P/E ratio
The latest P/E ratio of Medifast (MED) is 42.66, as of Sep 23, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Medifast’s last 12-month average P/E ratio is 16.07, compared to its current P/E ratio of 42.66. This reflects a increase of 165.46%.
Medifast’s current P/E ratio of 42.66 is higher than its last 12-month average P/E of 16.07. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Medifast’s average P/E ratio over the last 3 years is 10.14. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Medifast’s average P/E ratio over the last 5 years is 13.48. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.